Chinese herbal medicines for hypertriglyceridaemia

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Liu, Zhao Lan ^a,b   Li, George Q ^b   Bensoussan, Alan ^c   Kiat, Hosen ^d   Chan, Kelvin ^b,c   Liu, Jian Ping ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BENZBROMARONE; CHINESE DRUG; FENOFIBRATE; GEMFIBROZIL; PLACEBO; TRIACYLGLYCEROL;

ACUTE DISEASE; ADVERSE EVENT; ADVERSE OUTCOME; ARTHRITIS; CAUSE OF DEATH; CHINESE MEDICINE; CLINICAL OUTCOME; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY COLIC; LIFESTYLE MODIFICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; STOMACH PAIN; SYSTEMATIC REVIEW; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84901289014     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009560.pub2     Document Type: Review

References (43)

1. Liu YQ, Shi SQ, Zhao Y, Lu JS, Li YF, Yan WH, et al.Therapeutic effect of uric-acid-sequester herbal extract on the primary hyperuricemia and hypertriglyceridemia. Clinical Practice Medicine 2008;3(34):60-6.
2. Miao GZ, Wang YJ, Cao PL, Zhu XM, Wang LQ, Miu Juan, et al.The clinical observation of integrative medicine for type 2 diabetes and hypertriglyceridaemia patients. Beijing Journal of Traditional Chinese Medicine 2008;27(6):458-9.
3. Tan N, Huang SG, Zhou RY, Li DY, Zhu HJ. Clinical observation of Chushihuayu decoction on the treatment of hyperuricemia and hypertriglyceridemia. Chinese Journal of Information on Traditional Chinese Medicine 2010;17(3):9-11.
4. Cui AQ, Liu GR. The observation of clinical effectiveness of Lipi Tiaozhi capsule on hypertriglyceridaemia. Shandong Journal of Traditional Chinese Medicine 2005;24(7):398-9.
5. Feng YY, Li NF. The observation on effectiveness and safety of Xuezhikang on hyperlipidaemia patients. Journal of Chinese Medicine Research 2004;4(10):883-5.
6. Li H. The observation of effectiveness of Tiedanxin soft capsule for hypertriglyceridaemia. Chinese Medicine Modern Distance 2010;8(16):79-80.
7. Lin SM, Chen SW, Chen C. A clinical study of Guben Jiangzhi pill for old patients with hyperlipoproteinemia - with the data analysis of 160 cases. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 1999;13(1):16-9.
8. Liu YT, Wang ZY. The effectiveness of Cattail pollen capsule on 58 dyslipidaemia patients. Chinese Journals of Practical Medicine 2006;1(6):63-4.
9. Lv SF, Cao KQ, Wang PY. The clinical observation of Modified Zexie decoction on hyperlipidaemia. Clinical Journal of Traditional Chinese Medicine 2005;17(5):454-5.
10. Yang AN, Xu YX, Yang BP, Li D. 40 cases of familial hypertriglyceridaemia treated with Qiwu Taozhi granule. Gansu Journal of Traditional Chinese Medicine 2009;22(3):27-8.
11. Anderson F, Mbatha SZ, Thomson SR. The early management of pancreatitis associated with hypertriglyceridaemia. South African Journal of Surgery 2011;49(2):82-4. [PUBMED: 21614978]
12. Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?. Circulation 2006; Vol. 113, issue 12:1553-5. [PUBMED: 16567579]
13. Beltowski J, Wojcicka G, Jamroz-wisniewska A. Adverse effects of statins - mechanisms and consequences. Current Drug Safety 2009; Vol. 4, issue 3:209-28.
14. Chait A, Brunzell JD. Chylomicronemia syndrome. Advances in Internal Medicine 1992;37:249-73. [PUBMED: 1557997]
15. Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2, 000 mg/dl) hypertriglyceridemia in United States adults. American Journal of Cardiology 2011;107(6):891-7. [PUBMED: 21247544]
16. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
18. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
19. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 1996;3(2):213-9. [PUBMED: 8836866]
20. International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Pennsylvania: Parexel/Barnett, 1997.
21. Jacobson TA. Myopathy with statin-fibrate combination therapy: clinical considerations. Nature Reviews Endocrinology 2009; Vol. 5, issue 9:507-18.
22. Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. Journal of Ethnopharmacology 2008;119(2):291-8. [PUBMED: 18691646]
23. Jing A, Li-Mei Z, Yan-Jie L, Ben-Zhi C, Yong Z, Bao-Feng Y. A randomized, multicentre, open-label, parallel-group trial to compare the efficacy and safety profile of daming capsule in patients with hypercholesterolemia. Phytotherapy Research 2009;23(7):1039-42.
24. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
25. Kumar J, Wierzbicki AS. Images in clinical medicine. Lipemia retinalis. The New England Journal of Medicine 2005;353(8):823. [PUBMED: 16120862]
26. Le NA, Walter MF. The role of hypertriglyceridemia in atherosclerosis. Current Atherosclerosis Reports 2007;9(2):110-5. [PUBMED: 17877919]
27. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, et al.[A description on the Chinese national nutrition and health survey in 2002]. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26(7):478-84. [PUBMED: 16334996]
28. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al.The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 1999;6(7):1-28. [DOI: 10.1371/journal.pmed.1000100]
29. Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fonnebo V. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chinese Medical Journal 2006;23:1-4.
30. Martinez DP, Diaz JO, Bobes CM. Eruptive xanthomas and acute pancreatitis in a patient with hypertriglyceridemia. International Archives of Medicine 2008;1(1):6. [PUBMED: 18474088]
31. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
32. Mota M, Panus C, Mota E, Lichiardopol C, Vladu D, Toma E. The metabolic syndrome - a multifaced disease. Romanian Journal of Internal Medicine 2004;42(2):247-55. [PUBMED: 15529615]
33. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsNational Cholesterol Education Program (NCEP). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
34. Pocock, S.J. Clinical Trials: A Practical Approach. John Wiley & Sons, UK, 1990.
35. Schulz KF, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. JAMA 1995;273(5):408-12.
36. Sun YC. Treatment of 60 cases of hypertriglyceridemia with Huayuchushisan. Shanxi Journal of Traditional Chinese Medicine 2009;30(9):1163.
37. Wang YZ, Han XL. Clinical observation on hypertriglyceridemia treated by Yiqisanju formula in 24 patients. Hebei Journal of Traditional Chinese Medicine 2010;32(7):999.
38. Wei ASH, Ye JH, Chen P, Jian KK, Liu T, Lang JM. Effects of Yinchenwulingsan on insulin resistance of hypertriglyceridemia patients. New Journal of Traditional Chinese Medicine 2006;38(11):44.
39. WHO. Noncommunicable diseases in South-East Asia region: a profile. http://209.61.208.233/LinkFiles/NCD_InforBase_ncd-profile.pdf (accessed April 10, 2013).
40. Xing Y, Yue P, Sun LH, Zhao WX, Wang Y, Zhang Y, et al.[Effect of Daming capsule on expression of connexin43 isoforms in hyperlipemic rat's cardiac muscle]. Zhongguo Zhong Yao Za Zhi 2007;32(14):1440-5. [PUBMED: 17966361]
41. Zhai ZS, Han XL. Treatment of 24 cases of hypertriglyceridemia with Buyang Huanwu decoction. Hebei Journal of Traditional Chinese Medicine 2007;29(9):807.
42. Zhang SJ, Cheng ZX, Lin YW, Qin J, Cheng YH, Liu SL. [Effection of composite salviae dropping pill on hyperlipemia patients with phlegm and blood stasis syndrome]. Zhongguo Zhong Yao Za Zhi 2007;32(5):440-3.
43. Zhang J, Dong Z, Li G, Jiao SF, Xie J, Zhou Y, et al.A cross-sectional study on risk factors of associated type 2 diabetes mellitus among adults in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 2011;32(4):357-60. [PUBMED: 21569666]